Drug Res (Stuttg) 2013; 63(11): 591-596
DOI: 10.1055/s-0033-1349089
Original Article
© Georg Thieme Verlag KG Stuttgart · New York

The Effect of Beta-Cyclodextrin on Percutaneous Absorption of Commonly Used Eusolex® Sunscreens

J. Shokri
2   Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran
3   Dermatology & Dermopharmacy Research Team, Tabriz University of Medical Sciences, Tabriz, Iran
D. Hasanzadeh
2   Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran
S. Ghanbarzadeh
2   Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran
4   Students Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran
M. Dizadji-Ilkhchi
2   Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran
4   Students Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran
K. Adibkia
1   Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
2   Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran
› Author Affiliations
Further Information

Publication History

received 29 May 2013

accepted 06 June 2013

Publication Date:
10 July 2013 (online)



There is a serious concern about the topical and systemic absorption of organic ultraviolet filters in sunscreen formulations and subsequent phototoxic and photo allergic reactions. Ideally, a sunscreen should localize in the surface of stratum corneum and create a barrier against UV radiation, but not penetrate into the underlying viable tissues and systemic circulation.


The objective of the present study was to determine the effects of β-cyclodextrin (β-CDX) complexation on the transdermal penetration of 3 commonly used sun blocking agents, Eusolex ® 4360 (avobenzone), Eusolex ® 9020 (Oxybenzone) and Eusolex ® 232 (Ensulizole).


The complexation of the sunscreen agents with β-CDX was performed by 3 methods and confirmed by differential scanning calorimetry (DSC). Sunscreens, and their physical mixtures and complexes with β-CDX were introduced into a model cream base (o/w emulsion). To find out the influence of β-CDX, sunscreen creams were applied to the rat skin in vitro in standard Franz diffusion cells and the amount of sunscreen permeated after 6 h was assessed by HPLC.


The skin penetration flux of the UV filters was significantly reduced (4–15 fold) by complexation with β-CDX. Complexation also could prolong absorption lag time of sun blocking agents to more than 150 min.


Considering the ability of β-CDX complexation in the reduction of flux and enhancement ratio as well as prolongation of absorption lag time, this technique could be very helpful for reducing systemic absorption of the UV filters and subsequent toxicity and allergic reaction.

  • References

  • 1 Botta C, Di Giorgio C, Sabatier A-S et al. Genotoxicity of visible light (400–800 nm) and photoprotection assessment of ectoin, l-ergothioneine and mannitol and four sunscreens. J Photochem Photobiol B: Biol 2008; 91: 24-34
  • 2 Brausch JM, Rand GM. A review of personal care products in the aquatic environment: Environmental concentrations and toxicity. Chemosphere 2011; 82: 1518-1532
  • 3 Chetelat A, Dresp JH, Gocke E. Photomutagenesis test development: II. 8-methoxypsoralen, chlorpromazine and sunscreen compounds in chromosomal aberration assays using CHO cells. Mutation Research/Environmental Mutagenesis and Related Subjects. 1993; 292: 251-258
  • 4 Crovara Pescia A, Astolfi P, Puglia C et al. On the assessment of photostability of sunscreens exposed to UVA irradiation: From glass plates to pig/human skin, which is best?. Int J Pharm 2012; 427: 217-223
  • 5 Gaspar LR, Campos PMBGM. Photostability and efficacy studies of topical formulations containing UV-filters combination and vitamins A, C and E. Int J Pharm 2007; 343: 181-189
  • 6 Gonzalez S, Fernandez-Lorente M, Gilaberte-Calzada Y. The latest on skin photoprotection. Clin Dermatol 2008; 26: 614-626
  • 7 Couteau C, Couteau O, Alami-El Boury S et al. Sunscreen products: What do they protect us from?. Int J Pharm 2011; 415: 181-184
  • 8 Einspahr JG, Stratton SP, Bowden GT et al. Chemoprevention of human skin cancer. Crit Rev Oncol Hematol 2002; 41: 269-285
  • 9 Gaspar LR, Maia Campos PMBG. Evaluation of the photostability of different UV filter combinations in a sunscreen. Int J Pharm 2006; 307: 123-128
  • 10 Kullavanijaya P, Lim HW.. Photoprotection. J Am Acad Dermatol 2005; 52: 937-958
  • 11 Nikolic S, Keck CM, Anselmi C et al. Skin photoprotection improvement: Synergistic interaction between lipid nanoparticles and organic UV filters. Int J Pharm 2011; 414: 276-284
  • 12 Pathak MA. Sunscreens: Topical and systemic approaches for protection of human skin against harmful effects of solar radiation. J Am Acad Dermatol 1982; 7: 285-312
  • 13 Sambandan DR, Ratner D. Sunscreens: An overview and update. J Am Acad Dermatol 2011; 64: 748-758
  • 14 Schaefer H, Moyal D, Fourtanier A. Recent advances in sun protection. Semin Cutan Med Surg 1998; 17: 266-275
  • 15 Cal K, Centkowska K. Use of cyclodextrins in topical formulations: Practical aspects. Eur J Pharm Biopharm 2008; 68: 467-478
  • 16 Pardeike J, Hommoss A, Müller RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm 2009; 366: 170-184
  • 17 Scalia S, Tursilli R, Bianchi A et al. Incorporation of the sunscreen agent, octyl methoxycinnamate in a cellulosic fabric grafted with β-cyclodextrin. Int J Pharm 2006; 308: 155-159
  • 18 Scalia S, Villani S, Scatturin A et al. Complexation of the sunscreen agent, butyl-methoxydibenzoylmethane, with hydroxypropyl-β-cyclodextrin. Int J Pharm 1998; 175: 205-213
  • 19 Touitou E, Godin B. Skin nonpenetrating sunscreens for cosmetic and pharmaceutical formulations. Clin Dermatol 2008; 26: 375-379
  • 20 Wang SQ, Tooley IR. Photoprotection in the Era of Nanotechnology. Semin Cutan Med Surg 2011; 30: 210-213
  • 21 Lopez-García MA, Lopez O, Maya I et al. Complexation of hydroxytyrosol with β-cyclodextrins. An efficient photoprotection. Tetrahedron 2010; 66: 8006-8011
  • 22 Scalia S, Molinari A, Casolari A et al. Complexation of the sunscreen agent, phenylbenzimidazole sulphonic acid with cyclodextrins: effect on stability and photo-induced free radical formation. Eur J Pharm Sci 2004; 22: 241-249
  • 23 Scalia S, Tursilli R, Iannuccelli V. Complexation of the sunscreen agent, 4-methylbenzylidene camphor with cyclodextrins: Effect on photostability and human stratum corneum penetration. J Pharm Biomed Anal 2007; 44: 29-34
  • 24 Hung C-F, Fang C-L, Al-Suwayeh SA et al. Evaluation of drug and sunscreen permeation via skin irradiated with UVA and UVB: Comparisons of normal skin and chronologically aged skin. J Dermatol Sci 2012; 68: 135-148
  • 25 Molina-Molina J-M, Escande A, Pillon A et al. Profiling of benzophenone derivatives using fish and human estrogen receptor-specific in vitro bioassays. Toxicol Appl Pharmacol 2008; 232: 384-395
  • 26 Nash JF. Human Safety and Efficacy of Ultraviolet Filters and Sunscreen Products. Dermatol Clin 2006; 24: 35-51
  • 27 Rhodes MC, Bucher JR, Peckham JC et al. Carcinogenesis studies of benzophenone in rats and mice. Food Chem Toxicol 2007; 45: 843-851
  • 28 Soeborg T, Ganderup N-C, Kristensen JH et al. Distribution of the UV filter 3-benzylidene camphor in rat following topical application. J Chromatogr B 2006; 834: 117-121
  • 29 Nokhodchi A, Shokri J, Dashbolaghi A et al. The enhancement effect of surfactants on the penetration of lorazepam through rat skin. Int J Pharm 2003; 250: 359-369
  • 30 Shokri J, Nokhodchi A, Dashbolaghi A et al. The effect of surfactants on the skin penetration of diazepam. Int J Pharm 2001; 228: 99-107
  • 31 Javadzadeh Y, Shokri J, Hallaj-Nezhadi S et al. Enhancement of percutaneous absorption of Finasteride by cosolvents, cosurfactant and surfactants. Pharm Dev Technol 2010; 15: 619-625
  • 32 Shokri J, Azarmi S, Hallaj-Nezhadi S et al. Effects of various penetration enhancers on percutaneous absorption of piroxicam from emulgels. Research in Pharmaceutical Sciences 2012; 7: 225-234
  • 33 Aigner Z, Berkesi O, Farkas G et al. DSC, X-ray and FTIR studies of a gemfibrozil/dimethyl-β-cyclodextrin inclusion complex produced by co-grinding. J Pharm Biomed Anal 2012; 57: 62-67
  • 34 Karadzovska D, Brooks JD, Monteiro-Riviere NA et al. Predicting skin permeability from complex vehicles. Adv Drug Delivery Rev 2012;
  • 35 Liu L, Zhu S. A study on the supramolecular structure of inclusion complex of β-cyclodextrin with prazosin hydrochloride. Carbohydr Polym 2007; 68: 472-476
  • 36 Marques HMC, Hadgraft J, Kellaway IW. Studies of cyclodextrin inclusion complexes. I. The salbutamol-cyclodextrin complex as studied by phase solubility and DSC. Int J Pharm 1990; 63: 259-266
  • 37 Spada G, Gavini E, Cossu M et al. Evaluation of the effect of hydroxypropyl-β-cyclodextrin on topical administration of milk thistle extract. Carbohydr Polym 2013; 92: 40-47
  • 38 Vianna RFL, MVLB Bentley, Ribeiro G et al. Formation of cyclodextrin inclusion complexes with corticosteroids: their characterization and stability. Int J Pharm 1998; 167: 205-213
  • 39 Wang Jh, Cai Z. Investigation of inclusion complex of miconazole nitrate with β-cyclodextrin. Carbohydr Polym 2008; 72: 255-260
  • 40 Williams Iii RO, Mahaguna V, Sriwongjanya M. Characterization of an inclusion complex of cholesterol and hydroxypropyl-β-cyclodextrin. Eur J Pharm Biopharm 1998; 46: 355-360
  • 41 Hexsel CL, Bangert SD, Hebert AA et al. Current sunscreen issues: 2007 Food and Drug Administration sunscreen labelling recommendations and combination sunscreen/insect repellent products. J Am Acad Dermatol 2008; 59: 316-323
  • 42 Nohynek GJ, Schaefer H. Benefit and Risk of Organic Ultraviolet Filters. Regul Toxicol Pharmacol 2001; 33: 285-299
  • 43 Urbach F. The historical aspects of sunscreens. J Photochem Photobiol B: Biol 2001; 64: 99-104